© Reuters. Chairman Rep. Anna Eshoo (D-CA) attends a House Energy and Commerce Subcommittee on Health hearing in Washington
By Carl O’Donnell
(Reuters) – A Democratic U.S. lawmaker urged the Biden administration to involve additional major healthcare distributors in the shipment of COVID-19 vaccines to speed vaccinations, according to a letter seen by Reuters.
The Trump administration signed an exclusive deal with healthcare distributor McKesson Corp (NYSE:) to ship COVID-19 vaccines for the government. That distribution system has broadly worked, but it will face new demands as vaccines from Johnson & Johnson (NYSE:) and other companies are expected to be added.
“Given the scale of vaccinations needed in response to this pandemic … I encourage you to consider utilizing all distributors and the full infrastructure of our commercial pharmaceutical distribution network,” Representative Anna Eshoo wrote in the letter, which was dated Jan. 28 and addressed to Jeff Zients, the White House coronavirus response coordinator.
Eshoo is the chair of the House of Representatives Energy and Commerce Committee’s Subcommittee on Health.
Reuters reported on Thursday that federal officials are talking to U.S. pharmaceutical distributors about increasing the number of companies shipping coronavirus vaccines, but have not yet made a final decision.
Eshoo cited a report by the Center for American Progress, a think-tank, that suggested enlisting all three of the largest U.S. healthcare distributors — Cardinal Health Inc (NYSE:), McKesson Corp and AmerisourceBergen (NYSE:) Corp — in the COVID vaccine shipping efforts.
Cardinal Health and AmerisourceBergen have made proposals to the administration to take on some distribution, Reuters reported.
President Joe Biden has called the initial phase of the vaccination campaign a “dismal failure” and plans to expand and improve the program in a bid to make vaccines available to all Americans by mid-year.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
No comments:
Post a Comment